Health & Pharm General

Mental Health Meets AI: Australian Founder Makes History at the Women Leading Tech Awards

🕔4/8/2025 8:30:42 AM

Australian psychologist and entrepreneur Marika Conomos, founder and CEO of UpLift AI, has made history at the Women Leading Tech Awards 2025, hosted by Atlassian, becoming the first individual to win three of the night’s top honours.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation Morgan Stanley Alpha ex-100 Conference

🕔4/8/2025 8:23:35 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, will give an investor briefing at the Alpha ex-100 Conference hosted by Morgan Stanley in Sydney today.

Read Full Article

Medland Orthodontics Achieves Prestigious Blue Diamond Invisalign Provider Status for Second Consecutive Year

🕔4/8/2025 4:05:15 AM

Medland Orthodontics has been recognised as one of Australia’s top Invisalign® Providers, earning the coveted Blue Diamond Provider status for the second consecutive year—an accolade awarded only to the highest-performing Invisalign practices globally.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Appoints Clinical Advisory Board for PromarkerEso

🕔4/7/2025 8:26:24 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) is pleased to announce the formation of its Clinical Advisory Board for its world-first diagnostic blood test to identify esophageal cancer, specifically esophageal adenocarcinoma, PromarkerEso.

Read Full Article

Inqtel Explores Potential in Cancer Therapy Research

🕔4/7/2025 7:34:58 AM

Inqtel Pty Ltd Announces Expansion into Cancer Therapeutics, Exploring Novel Treatment with Potential Inqtel Pty Ltd, an Australian research and development company originally specializing in fintech innovation, today announced an expansion of its operations into the pharmaceutical sector, specifically focusing on the exploration of potential cancer therapeutics.

Read Full Article

NEXT Life Sciences Announces Successful Plan A™ Delivery Device Clinical Trial in Australia

🕔4/3/2025 9:04:59 PM

NEXT Life Sciences, the modern reproductive healthcare company pioneering Plan A™, a first-of-its-kind, long-lasting, and on-demand reversible male contraceptive in development, announces the successful completion of its clinical trial in Australia with a 100% success rate.

Read Full Article

April is Autism Awareness Month: Why Workplace Reform for Neurodivergent Employees Is a Business Imperative

🕔4/3/2025 12:00:00 PM

As National Autism Awareness Month begins, advocates and researchers are calling on employers to adopt more inclusive workplace practices to better support employees with autism spectrum disorder (ASD).

Read Full Article